Dr. Blauel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2014 - 2017
State University of New York Downstate Medical Center College of MedicineClass of 2014
Certifications & Licensure
CO State Medical License 2022 - 2025
PA State Medical License 2017 - 2022
NY State Medical License 2015 - 2020- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma Start of enrollment: 2023 Oct 24
Roles: Contact
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors Start of enrollment: 2021 Oct 18
Roles: Contact
Publications & Presentations
PubMed
- 10 citationsThe promise of TRK inhibitors in pediatric cancers with NTRK fusions.Emily R Blauel, Theodore W Laetsch
Cancer Genetics. 2022-04-01 - Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.Emily R. Blauel, Lily T. Grossmann, Madhav Vissa, Scott T. Miller
Journal of Pediatric Hematology/oncology. 2015-10-01
Press Mentions
Genomic Insights Drive Pediatric Cancer Research ForwardSeptember 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
